+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genomic Biomarker Market by Product Type, Technology, Application, End User, Biomarker Type - Global Forecast to 2030- Product Image
Genomic Biomarker Market by Product Type, Technology, Application, End User, Biomarker Type - Global Forecast to 2030- Product Image
Sale

Genomic Biomarker Market by Product Type, Technology, Application, End User, Biomarker Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977839
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genomic biomarker market is rapidly evolving, with life sciences innovation and precision healthcare driving new adoption across diagnostics, drug development, and patient-focused research. Senior decision-makers seeking to capitalize on technology shifts and regional demand will find actionable market intelligence essential for success.

Market Snapshot: Genomic Biomarker Market Overview

The Genomic Biomarker Market grew from USD 4.67 billion in 2024 to USD 4.99 billion in 2025. It is expected to continue growing at a CAGR of 6.77%, reaching USD 6.92 billion by 2030. This sustained growth signals strong demand for advanced instruments, reagents, services, and integrated platforms across research, clinical, and pharmaceutical sectors. Expansion is being shaped by regulatory advancements, supply chain adaptations, and technology upgrades as organizations invest in precision medicine and personalized therapeutics.

Scope & Segmentation: Comprehensive Genomic Biomarker Landscape

  • Product Types: Mass spectrometry systems (GC-MS, LC-MS/MS, MALDI-TOF), microarray systems (gene expression, protein, SNP arrays), PCR systems (digital PCR, qPCR, RT-PCR), sequencers (next-generation, Sanger models), and a broad range of reagents and kits including consumables, specialized enzymes, probes, library prep, microarray, and PCR kits. Service offerings cover bioinformatics, custom assay development, data analysis, and exome, RNA, targeted, and whole genome sequencing services.
  • Technologies: Deployments include mass spectrometry, microarray, next-generation sequencing, and polymerase chain reaction platforms, each serving distinct research and clinical workflows.
  • Applications: Utilized across diagnostics such as genetic, infectious disease, oncology, and pharmacogenomic testing, as well as drug discovery (lead optimization, screening, target identification and validation), personalized medicine (companion diagnostics, predictive biomarkers, stratified medicine), and basic, clinical, and translational research.
  • End Users: Academic and research institutes, contract research organizations, hospitals, diagnostic laboratories, pharmaceutical, and biotechnology companies drive the market through targeted adoption and investment.
  • Biomarker Types: Key categories encompass DNA (copy number variation, methylation, point mutations, structural variation), epigenetic (chromatin accessibility, DNA methylation, histone modification), protein (phosphoproteomics, proteomics), and RNA (lncRNA, miRNA, mRNA).
  • Regional Coverage: Analysis includes Americas (with leading coverage of U.S. regions and major economies in Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (covering major and emerging markets), and Asia-Pacific (China, India, Japan, Australia, South Korea, and Southeast Asian nations).

Key Takeaways: Actionable Insights for Senior Decision-Makers

  • Regulatory agencies continue to update frameworks, paving ways for faster clinical validation and broader adoption of biomarker-driven therapeutics.
  • Multi-omics technologies, including integrated proteomic and transcriptomic platforms, are reshaping research approaches by yielding deeper biological insights.
  • Precision medicine’s momentum is spurring strategic investments among pharmaceutical, biotechnology, and diagnostic providers, impacting product development and regional expansion plans.
  • Direct-to-consumer testing’s rise emphasizes the need for robust data privacy standards and seamless clinical integration to support both patient engagement and provider workflows.
  • Major suppliers and service providers are adopting bundled partnership models to offer predictability in costs and service delivery, responding to new cost pressures and operational complexity.
  • Leading companies leverage cloud-based data solutions and real-time analytics to drive operating efficiencies, regulatory compliance, and faster market access for novel assays.

Tariff Impact: Navigating 2025 U.S. Trade Policy Changes

New U.S. tariffs on imported instrumentation and raw materials are reshaping supply and pricing structures across the genomic biomarker ecosystem. Manufacturers have responded by localizing critical production and optimizing sourcing, while laboratories are restructuring procurement and optimizing assay protocols to manage higher reagent and consumable costs. Service providers and end users are leveraging bundled agreements to stabilize budgets and ensure continuity amid changing trade conditions.

Methodology & Data Sources

This report integrates extensive secondary research, in-depth primary interviews with industry stakeholders, and rigorous data triangulation. Sector leaders, manufacturers, and end-user laboratories participated in validation exercises. Data sources include public literature, regulatory filings, industry reports, and corporate financials.

Why This Report Matters

  • Enables informed investment and operational strategy by delivering a complete view of the genomic biomarker market’s evolving landscape.
  • Equips leadership with practical recommendations on supply chain resilience, regulatory pathways, and digital transformation initiatives.
  • Supports risk mitigation and opportunity identification for organizations aiming to enhance their precision medicine and clinical genomics portfolios.

Conclusion

The genomic biomarker market’s dynamic transformation is creating new opportunities for research, clinical adoption, and commercialization. Leaders who align strategic investments with regulatory, technological, and supply chain trends will advance precision healthcare and organizational growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Genomic Biomarker Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Mass Spectrometry Systems
8.2.1.1. GC-MS
8.2.1.2. LC-MS/MS
8.2.1.3. MALDI-TOF
8.2.2. Microarray Systems
8.2.2.1. Gene Expression Arrays
8.2.2.2. Protein Arrays
8.2.2.3. Snp Arrays
8.2.3. Pcr Systems
8.2.3.1. Digital PCR
8.2.3.2. qPCR
8.2.3.3. Rt-PCR
8.2.4. Sequencers
8.2.4.1. Next-Generation Sequencers
8.2.4.2. Sanger Sequencers
8.3. Reagents & Kits
8.3.1. Consumables
8.3.1.1. Enzymes
8.3.1.2. Probes & Primers
8.3.2. Kits
8.3.2.1. Library Prep Kits
8.3.2.2. Microarray Kits
8.3.2.3. Pcr Kits
8.4. Services
8.4.1. Bioinformatics Services
8.4.2. Custom Assay Development
8.4.3. Data Analysis Services
8.4.4. Sequencing Services
8.4.4.1. Exome Sequencing
8.4.4.2. RNA Sequencing
8.4.4.3. Targeted Sequencing
8.4.4.4. Whole Genome Sequencing
9. Genomic Biomarker Market, by Technology
9.1. Introduction
9.2. Mass Spectrometry
9.2.1. GC-MS
9.2.2. LC-MS/MS
9.2.3. MALDI-TOF
9.3. Microarray
9.3.1. Gene Expression Arrays
9.3.2. Protein Arrays
9.3.3. SNP Arrays
9.4. Next-Generation Sequencing
9.4.1. Exome Sequencing
9.4.2. RNA Sequencing
9.4.3. Targeted Sequencing
9.4.4. Whole Genome Sequencing
9.5. Polymerase Chain Reaction
9.5.1. Digital PCR
9.5.2. qPCR
9.5.3. RT-PCR
10. Genomic Biomarker Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Genetic Testing
10.2.2. Infectious Disease Testing
10.2.3. Oncology Diagnostics
10.2.4. Pharmacogenomic Testing
10.3. Drug Discovery & Development
10.3.1. Lead Optimization
10.3.2. Screening
10.3.3. Target Identification
10.3.4. Target Validation
10.4. Personalized Medicine
10.4.1. Companion Diagnostics
10.4.2. Predictive Biomarkers
10.4.3. Stratified Medicine
10.5. Research
10.5.1. Basic Research
10.5.2. Clinical Research
10.5.3. Translational Research
11. Genomic Biomarker Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals & Diagnostic Laboratories
11.5. Pharmaceutical & Biotechnology Companies
12. Genomic Biomarker Market, by Biomarker Type
12.1. Introduction
12.2. DNA
12.2.1. Copy Number Variation
12.2.2. Methylation
12.2.3. Point Mutations
12.2.4. Structural Variations
12.3. Epigenetic
12.3.1. Chromatin Accessibility
12.3.2. DNA Methylation
12.3.3. Histone Modification
12.4. Protein
12.4.1. Phosphoproteomics
12.4.2. Proteomics
12.5. RNA
12.5.1. Lncrna
12.5.2. miRNA
12.5.3. mRNA
13. Americas Genomic Biomarker Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Genomic Biomarker Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Genomic Biomarker Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Illumina, Inc.
16.3.3. QIAGEN N.V.
16.3.4. Roche Holding AG
16.3.5. Danaher Corporation
16.3.6. Abbott Laboratories
16.3.7. Agilent Technologies, Inc.
16.3.8. Bio-Rad Laboratories, Inc.
16.3.9. PerkinElmer, Inc.
16.3.10. BGI Genomics Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENOMIC BIOMARKER MARKET MULTI-CURRENCY
FIGURE 2. GENOMIC BIOMARKER MARKET MULTI-LANGUAGE
FIGURE 3. GENOMIC BIOMARKER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENOMIC BIOMARKER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GENOMIC BIOMARKER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GENOMIC BIOMARKER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENOMIC BIOMARKER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENOMIC BIOMARKER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GC-MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LC-MS/MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RT-PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SANGER SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GC-MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LC-MS/MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RT-PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACOGENOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRATIFIED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COPY NUMBER VARIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY METHYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POINT MUTATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRUCTURAL VARIATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HISTONE MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 111. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2030 (USD MILLION)
TABLE 112. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 113. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHOSPHOPROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 114. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 115. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2030 (USD MILLION)
TABLE 116. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 117. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LNCRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 118. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MIRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 119. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 120. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 135. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 136. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 137. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 139. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 140. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 141. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 142. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 144. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
TABLE 145. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2030 (USD MILLION)
TABLE 146. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2030 (USD MILLION)
TABLE 147. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
TABLE 148. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 177. CANADA GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. CANADA GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 179. CANADA GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 180. CANADA GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 181. CANADA GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 182. CANADA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2030 (USD MILLION)
TABLE 183. CANADA GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 184. CANADA GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 185. CANADA GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 186. CANADA GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 187. CANADA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 188. CANADA GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. CANADA GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 190. CANADA GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 191. CANADA GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 192. CANADA GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 193. CANADA GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. CANADA GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 195. CANADA GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 196. CANADA GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 197. CANADA GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 198. CANADA GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. CANADA GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 200. CANADA GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
TABLE 201. CANADA GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2030 (USD MILLION)
TABLE 202. CANADA GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2030 (USD MILLION)
TABLE 203. CANADA GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
TABLE 204. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 207. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 208. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 209. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 211. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 212. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 213. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 215. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 217. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 218. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 219. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 220. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 222. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 223. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 224. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 225. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 227. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
TABLE 228. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2030 (USD MILLION)
TABLE 229. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2030 (USD MILLION)
TABLE 230. MEXICO GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
TABLE 231. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 233. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 234. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 235. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2030 (USD MILLION)
TABLE 237. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 238. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 239. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 240. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 241. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 242. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 244. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 245. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 246. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 247. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 249. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 250. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 251. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 252. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 254. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
TABLE 255. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2030 (USD MILLION)
TABLE 256. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2030 (USD MILLION)
TABLE 257. BRAZIL GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
TABLE 258. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 260. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 261. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 262. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 263. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2030 (USD MILLION)
TABLE 264. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 265. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 266. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 267. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 268. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 269. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 271. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 272. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 273. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 274. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 276. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 277. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 278. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 279. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 281. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
TABLE 282. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2030 (USD MILLION)
TABLE 283. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2030 (USD MILLION)
TABLE 284. ARGENTINA GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 316. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 318. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 328. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 332. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 334. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 336. UNITED KINGDOM GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
TABLE 337. UNITED KI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Genomic Biomarker market report include:
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Roche Holding AG
  • Danaher Corporation
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • BGI Genomics Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.92 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Genomics Biomarkers Market by Type, by Disease Indication, by Validation, by End- User, and by Region - Product Image

Genomics Biomarkers Market by Type, by Disease Indication, by Validation, by End- User, and by Region

  • Report
  • 200 Pages
  • Global
From
Genomic Biomarkers Market - Forecasts from 2025 to 2030 - Product Image

Genomic Biomarkers Market - Forecasts from 2025 to 2030

  • Report
  • 146 Pages
  • Global
From
Genomic Biomarker Market Report 2025 - Product Image

Genomic Biomarker Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Genomic Biomarker Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Genomic Biomarker Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 104 Pages
  • Global
From
Biomarkers Market by Biomarker Type, Technology, Application, End User, Biomarker Source - Global Forecast to 2030 - Product Image

Biomarkers Market by Biomarker Type, Technology, Application, End User, Biomarker Source - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From

About the Market

Genomic biomarkers are a type of biomarker that are used to identify and measure genetic material in a biological sample. They are used to detect genetic variations that can be used to diagnose and monitor diseases, predict drug response, and identify individuals at risk for certain conditions. Genomic biomarkers are used in a variety of applications, including personalized medicine, drug development, and diagnostics. Genomic biomarkers are typically identified through the analysis of DNA, RNA, and proteins. They can be used to detect genetic variations that are associated with diseases, such as cancer, and to identify individuals at risk for certain conditions. Genomic biomarkers can also be used to predict drug response and to monitor the progression of diseases. The genomic biomarker market is expected to grow significantly in the coming years, driven by advances in technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.